These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31593141)

  • 1. Coexistence of Fabry disease with IgM nephropathy: A case report.
    Wu H; Behera TR; Gong J; Shen Q
    Medicine (Baltimore); 2019 Oct; 98(41):e17566. PubMed ID: 31593141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of Fabry disease and IgA nephropathy: a report of two cases.
    Yin G; Wu Y; Zeng CH; Chen HP; Liu ZH
    Ir J Med Sci; 2014 Dec; 183(4):671-5. PubMed ID: 24913738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological characteristics of Fabry disease combined with IgA nephropathy in Chinese patients
.
    Yang N; Wang X; Xu F; Zeng C; Wang J; Liu Z
    Clin Nephrol; 2017 Apr; 87 (2017)(4):188-195. PubMed ID: 28157068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of female Fabry disease revealed by renal biopsy.
    Aratani S; Yamakawa H; Suzuki S; Otsuka T; Sakai Y; Shimizu A; Tsuruoka S
    CEN Case Rep; 2020 Feb; 9(1):24-29. PubMed ID: 31542871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course and pathological findings of two late-onset Fabry hemizygous patients including mulberry cell counts after enzyme replacement therapy.
    Shimohata H; Yamashita M; Ohgi K; Maruyama H; Takayasu M; Hirayama K; Kobayashi M
    CEN Case Rep; 2020 Aug; 9(3):237-242. PubMed ID: 32189245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemizygous Fabry disease associated with membranous nephropathy: A rare case report
.
    Zhou W; Ni Z; Zhang M
    Clin Nephrol; 2018 Sep; 90(3):227-231. PubMed ID: 29792392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fabry nephropathy in a female with superposed IgA glomerulonephritis].
    Pisani A; Sessa A; Sabbatini M; Andreucci MV; Fusco C; Balletta M; Cianciaruso B
    G Ital Nefrol; 2005; 22(4):385-9. PubMed ID: 16267800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranous nephropathy without vacuolated podocytes in Fabry disease treated with agalsidase-β and carbamazepine: A case report.
    Kanai T; Ito T; Aoyagi J; Yamagata T
    Medicine (Baltimore); 2022 Feb; 101(7):e28830. PubMed ID: 35363176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of latent heterozygous Fabry disease in a female living kidney donor candidate.
    Minami M; Mizuma E; Nakahara M; Oda Y; Yoshimine H; Tokunaga K; Mitsuke A; Yamada Y; Enokida H; Masutani K; Goto N; Ido A
    CEN Case Rep; 2021 Feb; 10(1):30-34. PubMed ID: 32712909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A heterozygous female with Fabry disease due to a novel α-galactosidase A mutation exhibits a unique synaptopodin distribution in vacuolated podocytes.
    Takahashi N; Yokoi S; Kasuno K; Kogami A; Tsukimura T; Togawa T; Saito S; Ohno K; Hara M; Kurosawa H; Hirayama Y; Kurose T; Yokoyama Y; Mikami D; Kimura H; Naiki H; Sakuraba H; Iwano M
    Clin Nephrol; 2015 May; 83(5):301-8. PubMed ID: 25295576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyturia is significantly elevated in untreated vs treated Fabry adult patients.
    Trimarchi H; Canzonieri R; Schiel A; Politei J; Stern A; Andrews J; Paulero M; Rengel T; Aráoz A; Forrester M; Lombi F; Pomeranz V; Iriarte R; Young P; Muryan A; Zotta E
    J Nephrol; 2016 Dec; 29(6):791-797. PubMed ID: 26842625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN).
    Fogo AB; Bostad L; Svarstad E; Cook WJ; Moll S; Barbey F; Geldenhuys L; West M; Ferluga D; Vujkovac B; Howie AJ; Burns A; Reeve R; Waldek S; Noël LH; Grünfeld JP; Valbuena C; Oliveira JP; Müller J; Breunig F; Zhang X; Warnock DG;
    Nephrol Dial Transplant; 2010 Jul; 25(7):2168-77. PubMed ID: 19833663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme replacement therapy and Fabry nephropathy.
    Warnock DG; Daina E; Remuzzi G; West M
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):371-8. PubMed ID: 20007680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemizygous Fabry disease associated with IgA nephropathy: a case report.
    Shimohata H; Yoh K; Takada K; Tanaka H; Usui J; Hirayama K; Kobayashi M; Yamagata K
    J Nephrol; 2009; 22(5):682-4. PubMed ID: 19810002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy.
    Fall B; Scott CR; Mauer M; Shankland S; Pippin J; Jefferson JA; Wallace E; Warnock D; Najafian B
    PLoS One; 2016; 11(12):e0168346. PubMed ID: 27992580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of Fabry Disease and Membranous Nephropathy.
    Liu Y; Xie H; Lin H; Chen S; Wang W; Zhao G; Zhang X
    Iran J Kidney Dis; 2016 Jan; 10(1):48-50. PubMed ID: 26837682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of Fabry nephropathy with histological features of oligonephropathy.
    Nishida M; Kosaka K; Hasegawa K; Nishikawa K; Itoi T; Tsukimura T; Togawa T; Sakuraba H; Hamaoka K
    Eur J Pediatr; 2014 Aug; 173(8):1111-4. PubMed ID: 23913314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AJKD Atlas of Renal Pathology: Fabry nephropathy.
    Najafian B; Fogo AB; Lusco MA; Alpers CE
    Am J Kidney Dis; 2015 Nov; 66(5):e35-6. PubMed ID: 26498420
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease.
    Aoyama Y; Ushio Y; Yokoyama T; Taneda S; Makabe S; Nishida M; Manabe S; Sato M; Kataoka H; Tsuchiya K; Nitta K; Mochizuki T
    Intern Med; 2020; 59(7):971-976. PubMed ID: 32238663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.
    Najafian B; Svarstad E; Bostad L; Gubler MC; Tøndel C; Whitley C; Mauer M
    Kidney Int; 2011 Mar; 79(6):663-670. PubMed ID: 21160462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.